The role of stress-response systems for the pathogenesis and progression of MS

被引:95
作者
Gold, SM
Mohr, DC
Huitinga, I
Flachenecker, P
Sternberg, EM
Heesen, C
机构
[1] Univ Hamburg, Hosp Eppendorf, Dept Neurol, D-20246 Hamburg, Germany
[2] Univ Calif Los Angeles, Sch Med, Dept Neurol, Multiple Sclerosis Program, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Sch Med, Ctr Psychoneuroimmunol, Neuropsychiat Inst, Los Angeles, CA 90095 USA
[4] Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Psychiat & Neurol, San Francisco, CA 94121 USA
[5] VUmc, Netherlands Inst Brain Res, NL-1105 AZ Amsterdam, Netherlands
[6] VUmc, MS Ctr, NL-1105 AZ Amsterdam, Netherlands
[7] Neurol Rehabil Zentrum Quellenhof, D-75323 Bad Wildbad, Germany
[8] NIMH, Integrat Neural Immune Program, Sect Neuroendocrine Immunol & Behav, NIH, Rockville, MD 20852 USA
关键词
D O I
10.1016/j.it.2005.09.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Disease progression in multiple sclerosis (MS) - an inflammatory demyelinating and neurodegenerative disease with a presumed T-cell driven autoimmune origin - has long been hypothesized to be associated with stress. However, this notion has only recently been supported by prospective clinical studies. Several clinical and molecular studies in MS and its animal models have recently shown disruptions in the communication between the immune system and the two major stress response systems, the hypothalamo-pituitary-adrenal (HPA) axis and the autonomic nervous system. Insensitivity to glucocorticoid and beta-adrenergic modulation might be involved in overshooting inflammation in MS, whereas hyperactivity of the HPA axis has been linked to neurodegeneration and increased disability. Here, we integrate findings from molecular, cellular, experimental, clinical and epidemiological research to describe the involvement of stress response systems in MS pathogenesis and progression.
引用
收藏
页码:644 / 652
页数:9
相关论文
共 70 条
[11]  
CONSENTINO M, 2002, J NEUROIMMUNOL, V133, P233
[12]   Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis [J].
Cutolo, M ;
Sulli, A ;
Pizzorni, C ;
Craviotto, C ;
Straub, RH .
NEUROENDOCRINE AND NEURAL REGULATION OF AUTOIMMUNE AND INFLAMMATORY DISEASE: MOLECULAR, SYSTEMS, AND CLINICAL INSIGHTS, 2003, 992 :107-117
[13]   Autonomic neural regulation of immunity [J].
Czura, CJ ;
Tracey, KJ .
JOURNAL OF INTERNAL MEDICINE, 2005, 257 (02) :156-166
[14]   Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors [J].
De Keyser, J ;
Wilczak, N ;
Leta, R ;
Streetland, C .
NEUROLOGY, 1999, 53 (08) :1628-1633
[15]   Astrocytic β2-adrenergic receptors and multiple sclerosis [J].
De Keyser, J ;
Zeinstra, E ;
Wilczak, N .
NEUROBIOLOGY OF DISEASE, 2004, 15 (02) :331-339
[16]   Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1 [J].
Del Rey, A ;
Klusman, I ;
Besedovsky, HO .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1998, 275 (04) :R1146-R1151
[17]   Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production [J].
DeRijk, RH ;
Eskandari, F ;
Sternberg, EM .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 151 (1-2) :180-188
[18]   Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis [J].
Erkut, ZA ;
Endert, E ;
Huitinga, I ;
Swaab, DF .
MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (03) :229-236
[19]   INCREASED ACTIVITY OF HYPOTHALAMIC CORTICOTROPIN-RELEASING HORMONE NEURONS IN MULTIPLE-SCLEROSIS [J].
ERKUT, ZA ;
HOFMAN, MA ;
RAVID, R ;
SWAAB, DF .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 62 (01) :27-33
[20]   Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis -: Association with cerebral inflammation [J].
Fassbender, K ;
Schmidt, R ;
Mössner, R ;
Kischka, U ;
Kühnen, J ;
Schwartz, A ;
Hennerici, M .
ARCHIVES OF NEUROLOGY, 1998, 55 (01) :66-72